Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction

Clinical trial NCT07586865 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07586865
Sponsor: Beijing Northland Biotech. Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myocardial Infarction (AMI)Acute Myocardial Infarction of Anterior Wall Acute Myocardial Infarction With ST Elevation Acute Myocardial Infarction of Left Ventricle Acute Myocardial Infarction With ST Segment Elevation

Start date: 2026-05-18
Primary completion: 2027-08-17
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.